Abstract

Amongst the global effects of coronavirus disease (COVID-19), one of the challenges faced by health practitioners is how to continue offering treatment to cancer patients. This crisis has led to the collaboration of medical experts to discuss new strategies in the wake of this pandemic. Oncology treatment guidelines have been modified around the world to ensure the safety of this immunocompromised population by reducing exposure to coronavirus through different isolation and teleconsultation measures while providing life-saving treatments in these unprecedented settings. This scoping review summarizes the changes in the treatment of cancer patients as mentioned in the most up-to-date literature available through the first half of the year 2020. It is composed of narrative reviews, discussion or opinion papers, and reviews of current treatment guidelines for multiple types of cancers, including the extra measures needed to avoid infection. This paper aims to provide evidence-based decisions on how to deliver treatment effectively without compromising cancer patients’ safety.

Keywords:COVID-19; SARS-CoV-2; Cancer Treatment; Pandemic

References

1. WHO Director-General’s opening remarks at the media briefing on COVID-19 (2020).
2. Coronavirus disease (COVID-19) – World Health Organization (2019).
3. Wu Y-C., et al. “The outbreak of COVID-19: An overview”. Journal of the Chinese Medical Association 3 (2020): 217-220.
4. Addeo A and Friedlaender A. “Cancer and COVID-19: Unmasking their ties”. Cancer Treatment Reviews 88 (2020): 102041.
5. Marcum M., et al. “COVID-19 pandemic and impact on cancer clinical trials: An academic medical center perspective”. Cancer Medicine 17 (2020): 6141-6146.
6. Tian J., et al. “Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study”. The Lancet Oncology 7 (2020): 893-903.
7. Salako O., et al. “Upheaval in cancer care during the COVID-19 outbreak”. Ecancer Medical Science 14 (2020): ed97.
8. Saini KS., et al. “Effect of the COVID-19 pandemic on cancer treatment and research”. The Lancet Haematology 6 (2020): e432-e435.
9. Yu J., et al. “SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China”. JAMA Oncology (2020).
10. Baldotto C., et al. “Lung Cancer and the COVID-19 pandemic: Recommendations from the Brazilian Thoracic Oncology Group”. Clinics 75 (2020): e2060.
11. Patel RJ., et al. “Early institutional head and neck oncologic and microvascular surgery practice patterns across the United States during the SARS-CoV-2 (COVID19) pandemic”. Head Neck 6 (2020): 1168-1172.
12. Barry A., et al. “Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective”. The Lancet Gastroenterology and Hepatology 8 (2020): 765-775.
13. Dingemans A-MC., et al. “Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic”. International Association for the Study of Lung Cancer 7 (2020): 1119-1136.
14. Han AY., et al. “Time for a Paradigm Shift in Head and Neck Cancer Management During the COVID-19 Pandemic”. Otolaryngology-Head and Neck Surgery Off J American Academy of Otolaryngology-Head and Neck Surgery 3 (2020): 447-454.
15. Turri-Zanoni M., et al. “Managing care for patients with sinonasal and anterior skull base cancers during the COVID-19 pandemic”. Head Neck7 (2020): 1503-1506.
16. Ueda M., et al. “Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal”. Journal of the National Comprehensive Cancer Network 4 (2020): 366-369.
17. Uwins C., et al. “COVID-19 and gynecological cancer: a review of the published guidelines”. The International Journal of Gynecological Cancer (2020).
18. Singh AP., et al. “Management of Lung Cancer During the COVID-19 Pandemic”. JCO Oncology Practice (2020): OP2000286.
19. Vordermark D. “Shift in indications for radiotherapy during the COVID-19 pandemic? A review of organ-specific cancer management recommendations from multidisciplinary and surgical expert groups”. Radiation Oncology Journal 1 (2020): 140.
20. Saverio SD., et al. “Coronavirus pandemic and colorectal surgery: practical advice based on the Italian experience”. Colorectal Disease 6 (2020): 625-634.
21. Zhao Z., et al. “Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID-19 epidemic”. Thorac Cancer6 (2020): 1752-1757.
22. Mistretta FA., et al. “A Guide for Oncologic Patient Management during Covid-19 Pandemic: The Initial Experience of an Italian Oncologic Hub with Exemplificative Focus on Uro-Oncologic Patients”. Cancers6 (2020).
23. Sheng JY., et al. “Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach”. JCO Oncology Practice (2020): OP2000364.
24. Williams VM., et al. “COVID-19 impact on timing of brachytherapy treatment and strategies for risk mitigation”. Brachytherapy4 (2020): 401-411.
25. Maio M., et al. “Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era”. Clinical Cancer Research 16 (2020): 4201-4205.
26. Nguyen NP., et al. “Older Cancer Patients during the COVID-19 Epidemic: Practice Proposal of the International Geriatric Radiotherapy Group”. Cancers5 (2020).
27. Vidya R., et al. “Should breast reconstruction and breast oncoplastic procedures be performed during the coronavirus pandemic? (2020).
28. Sternberg C., et al. “Oncology practice during COVID-19 pandemic: a fast response is the best response”. Revista da Associação Médica Brasileira 3 (2020): 338-344.
29. Marti C and Sánchez-Méndez JI. “Neoadjuvant endocrine therapy for luminal breast cancer treatment: a first-choice alternative in times of crisis, such as the COVID-19 pandemic (2020).
30. Mirnezami R., et al. “Preoperative radiotherapy for locally advanced rectal cancer during and after the COVID-19 pandemic”. British Journal of Surgery 8 (2020): e263-e263.
31. Marijnen CAM., et al. “International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic”. Journal of the European Society for Radiotherapy and Oncology 148 (2020): 213-215.
32. Skowron KB., et al. “Caring for Patients with Rectal Cancer During the COVID-19 Pandemic”. The Journal of Gastrointestinal Surgery Off J Society for Surgery of the Alimentary Tract 7 (2020): 1698-1703.
33. Alshamrani M., et al. “Practical strategies to manage cancer patients during the COVID-19 pandemic: Saudi Oncology Pharmacy Assembly Experts recommendations”. Journal of Oncology Pharmacy Practice Off Publ Inter Social Oncology Pharm Pract 6 (2020): 1429-1440.
34. Specht M., et al. “High-Efficiency Same-Day Approach to Breast Reconstruction During the COVID-19 Crisis”. Breast Cancer Research and Treatment 3 (2020): 679-688.
35. Omarini C., et al. “Cancer treatment during the coronavirus disease 2019 pandemic: Do not postpone, do it!”. The European Journal of Cancer 133 (2020): 29-32.
36. Indini A., et al. “Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey”. European Journal of Cancer 132 (2020): 17-23.
37. De Joode K., et al. “Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective”. European Journal of Cancer 136 (2020): 132-139.
38. Liang W., et al. “Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China”. The Lancet Oncology 3 (2020): 335-337.
39. Dai M., et al. “Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak”. Cancer Discovery 6 (2020): 783-791.
40. Xia Y., et al. “Risk of COVID-19 for patients with cancer”. The Lancet Oncology 4 (2020): e180.